Compare $CTKB vs $NAUT | Chartloom

Compare

$CTKB vs $NAUT

Cytek Biosciences Inc · Nautilus Biotechnology Inc

CTKB

Cytek Biosciences Inc

NAUT

Nautilus Biotechnology Inc

Compare $CTKB vs $NAUT

Comparing Cytek Biosciences Inc and Nautilus Biotechnology Inc

CTKBCytek Biosciences Inc

NAUTNautilus Biotechnology Inc

CTKBCytek Biosciences Inc

Market cap

$701M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.18x

Rev growth (TTM)

5.4%

YTD performance

10.4%

52W performance

39.2%

FCF yield

-1.7%

NAUTNautilus Biotechnology Inc

Market cap

$286M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

198.56x

Rev growth (TTM)

—

YTD performance

17.8%

52W performance

149.4%

FCF yield

-18.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTKB

NAUT

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

NAUT

Nautilus Biotechnology Inc

Market Cap

CTKB$701M

NAUT$286M

Enterprise Value

CTKB$637M

NAUT$273M

Price

CTKB$5.43

NAUT$2.25

P/E Ratio

CTKBN/A

NAUTN/A

P/S Ratio

CTKB3.39x

NAUT1,507.03x

EV/Sales

CTKB3.08x

NAUT1,437.73x

EV/EBITDA

CTKB1,027.69x

NAUT0.00x

P/B Ratio

CTKB2.37x

NAUT1.90x

P/FCF Ratio

CTKBN/A

NAUTN/A

EV/FCF

CTKB-52.35x

NAUT-5.27x

PEG Ratio

CTKBN/A

NAUTN/A

Forward P/E (NTM)

CTKBN/A

NAUTN/A

Forward P/S (NTM)

CTKB3.18x

NAUT198.56x

Revenue (TTM)

CTKB$207M

NAUT$190K

Revenue Growth (YoY)

CTKB5.4%

NAUTN/A

Forward Rev Growth

CTKB6.1%

NAUT881.2%

Gross Margin (TTM)

CTKB53.2%

NAUT92.1%

Operating Margin (TTM)

CTKB0.0%

NAUT0.0%

EBITDA Margin (TTM)

CTKB-17.9%

NAUT-32287.4%

Net Margin (TTM)

CTKB-39.0%

NAUT-29747.9%

FCF Margin (TTM)

CTKB-5.9%

NAUT-27295.3%

Net Income (TTM)

CTKB$-81M

NAUT$-57M

FCF (TTM)

CTKB$-12M

NAUT$-52M

EPS (TTM)

CTKB-$0.62

NAUT-$0.44

ROE (TTM)

CTKB-2353.0%

NAUT-3758.0%

ROA (TTM)

CTKB-1740.0%

NAUT-3083.0%

ROIC (TTM)

CTKB-2293.0%

NAUT-3758.0%

Cash

CTKB$74M

NAUT$13M

Debt

CTKB$10M

NAUT$0

Net Cash/Debt

CTKB$64M

NAUT$13M

Current Ratio (TTM)

CTKB4.48x

NAUT10.14x

Quick Ratio (TTM)

CTKB3.77x

NAUT9.73x

Debt/Equity (TTM)

CTKB0.03x

NAUT0.00x

Debt/Assets (TTM)

CTKB0.0%

NAUT0.0%

Interest Coverage (TTM)

CTKBN/A

NAUTN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

NAUT0.00x

Beta

CTKB1.15

NAUT0.78

52W Performance

CTKB39.2%

NAUT149.4%

YTD Performance

CTKB10.4%

NAUT17.8%

% from 52W High

CTKB-12.6%

NAUT-47.8%

% from 52W Low

CTKB64.0%

NAUT174.5%

Asset Turnover (TTM)

CTKB0.45x

NAUT0.00x

FCF Yield (TTM)

CTKB-1.7%

NAUT-18.1%

Earnings Yield (TTM)

CTKB-11.5%

NAUT-19.7%

Dividend Yield (TTM)

CTKBN/A

NAUTN/A

Rule of 40

CTKB-0.4

NAUT-27,295.3

EV/GP/RG

CTKB0.61

NAUT1.36

Ticker research

View CTKB research View NAUT research

Metric	CTKB Cytek Biosciences Inc	NAUT Nautilus Biotechnology Inc
Market & Valuation
Market Cap	$701M	$286M
Enterprise Value	$637M	$273M
Price	$5.43	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	1,507.03x
EV/Sales	3.08x	1,437.73x
EV/EBITDA	1,027.69x	0.00x
P/B Ratio	2.37x	1.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-5.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	198.56x
Revenue & Growth
Revenue (TTM)	$207M	$190K
Revenue Growth (YoY)	5.4%	N/A
Forward Rev Growth	6.1%	881.2%
Profitability
Gross Margin (TTM)	53.2%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-32287.4%
Net Margin (TTM)	-39.0%	-29747.9%
FCF Margin (TTM)	-5.9%	-27295.3%
Net Income (TTM)	$-81M	$-57M
FCF (TTM)	$-12M	$-52M
EPS (TTM)	-$0.62	-$0.44
ROE (TTM)	-2353.0%	-3758.0%
ROA (TTM)	-1740.0%	-3083.0%
ROIC (TTM)	-2293.0%	-3758.0%
Financial Health
Cash	$74M	$13M
Debt	$10M	$0
Net Cash/Debt	$64M	$13M
Current Ratio (TTM)	4.48x	10.14x
Quick Ratio (TTM)	3.77x	9.73x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	0.78
52W Performance	39.2%	149.4%
YTD Performance	10.4%	17.8%
% from 52W High	-12.6%	-47.8%
% from 52W Low	64.0%	174.5%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.00x
FCF Yield (TTM)	-1.7%	-18.1%
Earnings Yield (TTM)	-11.5%	-19.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-27,295.3
EV/GP/RG	0.61	1.36
Ticker research	View CTKB research	View NAUT research

Valuation

P/S Ratio

CTKB

3.39x

NAUT

1,507.03x

EV/FCF

CTKB

-52.35x

NAUT

-5.27x

Growth & revenue

Revenue Growth TTM

CTKB

5.4%

Forward Revenue Growth

NAUT

881.2%

CTKB

6.1%

Profitability & performance

Gross Margin

NAUT

92.1%

CTKB

53.2%

ROE

CTKB

-2353.0%

NAUT

-3758.0%

FCF Yield %

CTKB

-1.7%

NAUT

-18.1%

52-Week Performance

NAUT

149.4%

CTKB

39.2%

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

NAUT

Nautilus Biotechnology Inc

Market Cap

CTKB$701M

NAUT$286M

Enterprise Value

CTKB$637M

NAUT$273M

Price

CTKB$5.43

NAUT$2.25

P/E Ratio

CTKBN/A

NAUTN/A

P/S Ratio

CTKB3.39x

NAUT1,507.03x

EV/Sales

CTKB3.08x

NAUT1,437.73x

EV/EBITDA

CTKB1,027.69x

NAUT0.00x

P/B Ratio

CTKB2.37x

NAUT1.90x

P/FCF Ratio

CTKBN/A

NAUTN/A

EV/FCF

CTKB-52.35x

NAUT-5.27x

PEG Ratio

CTKBN/A

NAUTN/A

Forward P/E (NTM)

CTKBN/A

NAUTN/A

Forward P/S (NTM)

CTKB3.18x

NAUT198.56x

Revenue (TTM)

CTKB$207M

NAUT$190K

Revenue Growth (YoY)

CTKB5.4%

NAUTN/A

Forward Rev Growth

CTKB6.1%

NAUT881.2%

Gross Margin (TTM)

CTKB53.2%

NAUT92.1%

Operating Margin (TTM)

CTKB0.0%

NAUT0.0%

EBITDA Margin (TTM)

CTKB-17.9%

NAUT-32287.4%

Net Margin (TTM)

CTKB-39.0%

NAUT-29747.9%

FCF Margin (TTM)

CTKB-5.9%

NAUT-27295.3%

Net Income (TTM)

CTKB$-81M

NAUT$-57M

FCF (TTM)

CTKB$-12M

NAUT$-52M

EPS (TTM)

CTKB-$0.62

NAUT-$0.44

ROE (TTM)

CTKB-2353.0%

NAUT-3758.0%

ROA (TTM)

CTKB-1740.0%

NAUT-3083.0%

ROIC (TTM)

CTKB-2293.0%

NAUT-3758.0%

Cash

CTKB$74M

NAUT$13M

Debt

CTKB$10M

NAUT$0

Net Cash/Debt

CTKB$64M

NAUT$13M

Current Ratio (TTM)

CTKB4.48x

NAUT10.14x

Quick Ratio (TTM)

CTKB3.77x

NAUT9.73x

Debt/Equity (TTM)

CTKB0.03x

NAUT0.00x

Debt/Assets (TTM)

CTKB0.0%

NAUT0.0%

Interest Coverage (TTM)

CTKBN/A

NAUTN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

NAUT0.00x

Beta

CTKB1.15

NAUT0.78

52W Performance

CTKB39.2%

NAUT149.4%

YTD Performance

CTKB10.4%

NAUT17.8%

% from 52W High

CTKB-12.6%

NAUT-47.8%

% from 52W Low

CTKB64.0%

NAUT174.5%

Asset Turnover (TTM)

CTKB0.45x

NAUT0.00x

FCF Yield (TTM)

CTKB-1.7%

NAUT-18.1%

Earnings Yield (TTM)

CTKB-11.5%

NAUT-19.7%

Dividend Yield (TTM)

CTKBN/A

NAUTN/A

Rule of 40

CTKB-0.4

NAUT-27,295.3

EV/GP/RG

CTKB0.61

NAUT1.36

Ticker research

View CTKB research View NAUT research

Metric	CTKB Cytek Biosciences Inc	NAUT Nautilus Biotechnology Inc
Market & Valuation
Market Cap	$701M	$286M
Enterprise Value	$637M	$273M
Price	$5.43	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	1,507.03x
EV/Sales	3.08x	1,437.73x
EV/EBITDA	1,027.69x	0.00x
P/B Ratio	2.37x	1.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-5.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	198.56x
Revenue & Growth
Revenue (TTM)	$207M	$190K
Revenue Growth (YoY)	5.4%	N/A
Forward Rev Growth	6.1%	881.2%
Profitability
Gross Margin (TTM)	53.2%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-32287.4%
Net Margin (TTM)	-39.0%	-29747.9%
FCF Margin (TTM)	-5.9%	-27295.3%
Net Income (TTM)	$-81M	$-57M
FCF (TTM)	$-12M	$-52M
EPS (TTM)	-$0.62	-$0.44
ROE (TTM)	-2353.0%	-3758.0%
ROA (TTM)	-1740.0%	-3083.0%
ROIC (TTM)	-2293.0%	-3758.0%
Financial Health
Cash	$74M	$13M
Debt	$10M	$0
Net Cash/Debt	$64M	$13M
Current Ratio (TTM)	4.48x	10.14x
Quick Ratio (TTM)	3.77x	9.73x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	0.78
52W Performance	39.2%	149.4%
YTD Performance	10.4%	17.8%
% from 52W High	-12.6%	-47.8%
% from 52W Low	64.0%	174.5%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.00x
FCF Yield (TTM)	-1.7%	-18.1%
Earnings Yield (TTM)	-11.5%	-19.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-27,295.3
EV/GP/RG	0.61	1.36
Ticker research	View CTKB research	View NAUT research